Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02290600 · ClinicalTrials.gov registry record
Feasibility Study Using Run-to-Run Control to Optimize Continuous Glucose Sensor Bias
A clinical trial, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- 23
- Enrollment target
NCT02290600 is a clinical trial that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 23 participants.
The verdict
NCT02290600 has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of this 12 week feasibility study is to see how much more accurate a continuous glucose monitor (CGM) might be in individuals with type 1 diabetes if the investigators personalize sensor calibrations to the user, based on previous wear.
Interventions
- DEVICE Continuous Glucose Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02290600
The ClinicalTrials.gov registry entry for NCT02290600 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitor is the first listed.
NCT02290600 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02290600 about?
NCT02290600 is a clinical study titled "Feasibility Study Using Run-to-Run Control to Optimize Continuous Glucose Sensor Bias". The purpose of this 12 week feasibility study is to see how much more accurate a continuous glucose monitor (CGM) might be in individuals with type 1 diabetes if the investigators personalize sensor calibrations to the user, based on previous wear.
What is the current status of trial NCT02290600?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2015-01. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02290600?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE).
Who is sponsoring clinical trial NCT02290600?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.